Cargando…

Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. Despite the initial resection and chemotherapeutic treatment, relapse is common, which leads to poor survival rates in patients. A primary cause of recurrence is the persistence of ovarian cancer stem cells (OCSCs) with hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yaoqi, Yao, Lin, Wang, Chunyan, Xiong, Bing, Guo, Jing, Wang, Lian, Zhu, Jihui, Cheng, Zhongping, Liu, Shupeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991408/ https://www.ncbi.nlm.nih.gov/pubmed/35401749 http://dx.doi.org/10.1155/2022/6406122

Ejemplares similares

Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer
por: Ding, Jinye, et al.
Publicado: (2023)

Identification of Biomarkers for Predicting Ovarian Reserve of Primordial Follicle via Transcriptomic Analysis
por: Liu, Li, et al.
Publicado: (2022)

MCM2 in human cancer: functions, mechanisms, and clinical significance
por: Sun, Yaoqi, et al.
Publicado: (2022)

Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer
por: Gu, Fei, et al.
Publicado: (2019)

miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
por: Zhou, Yang, et al.
Publicado: (2022)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Pan-cancer integrated bioinformatics analysis reveals cuproptosis related gene FDX1 is a potential prognostic and immunotherapeutic biomarker for lower-grade gliomas
por: Huang, Wei, et al.
Publicado: (2023)

NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017)

Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
por: McEvoy, Lynda M., et al.
Publicado: (2015)

MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian cancer
por: Silasi, Dan-Arin, et al.
Publicado: (2007)

Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012)

Chemoresistance is associated with Beclin-1 and PTEN expression in epithelial ovarian cancers
por: YING, HUANCHUN, et al.
Publicado: (2015)

Overexpression of Cathepsin L is associated with chemoresistance and invasion of epithelial ovarian cancer
por: Sui, Hongying, et al.
Publicado: (2016)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
por: Muñoz-Galván, Sandra, et al.
Publicado: (2021)

Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
por: Luo, Ning, et al.
Publicado: (2022)

Comprehensive Analysis Reveals Distinct Immunological and Prognostic Characteristics of CD276/B7-H3 in Pan-Cancer
por: Ding, Jinye, et al.
Publicado: (2023)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
por: Yokoyama, Yoshihito, et al.
Publicado: (2014)

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
por: Cornelison, Robert, et al.
Publicado: (2017)

Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses
por: Zhang, Zhengmao, et al.
Publicado: (2019)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
por: Feng, Xiaojie, et al.
Publicado: (2019)

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis
por: Li, Yuan, et al.
Publicado: (2023)

MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer
por: Wu, Yuliang, et al.
Publicado: (2023)

Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer
por: Huang, Wei, et al.
Publicado: (2023)

Discovering drugs to overcome chemoresistance in ovarian cancers based on the cancer genome atlas tumor transcriptome profile
por: Wang, Fan, et al.
Publicado: (2017)

Chromatin target of protein arginine methyltransferase regulates invasion, chemoresistance, and stemness in epithelial ovarian cancer
por: Feng, Xiaojie, et al.
Publicado: (2019)

The involvement of small heat shock protein in chemoresistance in ovarian cancer - in vitro study
por: Wyciszkiewicz, Aleksandra, et al.
Publicado: (2021)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Chemoresistance Is Associated with MUC1 and Lewis y Antigen Expression in Ovarian Epithelial Cancers
por: Zhang, Danye, et al.
Publicado: (2013)

The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer
por: Savant, Sudha S., et al.
Publicado: (2018)

Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
por: Nakao, Sari, et al.
Publicado: (2020)

SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1
por: Gao, Wujiang, et al.
Publicado: (2022)

TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer
por: Zhang, Meiying, et al.
Publicado: (2017)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells
por: Zhu, Liancheng, et al.
Publicado: (2014)

CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
por: Dobbin, Zachary C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_p32cdr9s3og3gcnpf120ef0u52